Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) ...

CVS Health plans to exit the individual Obamacare health insurance business next year, leaving 1 million people in 17 states ...

CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2025.

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...

An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly ...

CVS Health Corporation ( NYSE: CVS) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial ...

It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are ...

Arkansas Governor Sarah Huckabee Sanders signed a first-of-its-kind law ... to sell pharmacy businesses. Experts said at the time that the reform would lessen revenue and market impact of the ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

CEO David Joyner highlighted a strong start to 2025, reporting adjusted EPS of $2.25 and adjusted operating income of $4.6 billion. Full-year 2025 adjusted EPS guidance was raised to $6 to $6.20. CVS ...

A new law signed by Governor Sarah Huckabee Sanders this week is set to shake up how pharmacy services are managed ... nation’s largest PBMs, including CVS Caremark, OptumRx, and Express Scripts.